Your browser doesn't support javascript.
loading
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.
Brenner, Andrew J; Peters, Katherine B; Vredenburgh, James; Bokstein, Felix; Blumenthal, Deborah T; Yust-Katz, Shlomit; Peretz, Idit; Oberman, Bernice; Freedman, Laurence S; Ellingson, Benjamin M; Cloughesy, Timothy F; Sher, Naamit; Cohen, Yael C; Lowenton-Spier, Noa; Rachmilewitz Minei, Tamar; Yakov, Niva; Mendel, Itzhak; Breitbart, Eyal; Wen, Patrick Y.
Afiliación
  • Brenner AJ; University of Texas Health San Antonio Mays Cancer Center, San Antonio, Texas, USA.
  • Peters KB; Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina, USA.
  • Vredenburgh J; Saint Francis Hospital and Medical Center, Hartford, Connecticut, USA.
  • Bokstein F; Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Blumenthal DT; Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Yust-Katz S; Neuro-Oncology Unit, Davidoff Cancer Center at Rabin Medical Center, Petach Tikvah, Israel and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Peretz I; Neuro-Oncology Unit, Davidoff Cancer Center at Rabin Medical Center, Petach Tikvah, Israel and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Oberman B; Biostatistics and Biomathematics Unit, Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Freedman LS; Biostatistics and Biomathematics Unit, Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Cloughesy TF; Department of Neurology, Ronald Reagan UCLA Medical Center, University of California Los Angeles, Los Angeles, California, USA.
  • Sher N; VBL Therapeutics, Modi'in, Israel.
  • Cohen YC; VBL Therapeutics, Modi'in, Israel.
  • Lowenton-Spier N; VBL Therapeutics, Modi'in, Israel.
  • Rachmilewitz Minei T; VBL Therapeutics, Modi'in, Israel.
  • Yakov N; VBL Therapeutics, Modi'in, Israel.
  • Mendel I; VBL Therapeutics, Modi'in, Israel.
  • Breitbart E; VBL Therapeutics, Modi'in, Israel.
  • Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Neuro Oncol ; 22(5): 694-704, 2020 05 15.
Article en En | MEDLINE | ID: mdl-31844886
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Terapia Genética / Glioblastoma Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Terapia Genética / Glioblastoma Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos